01 April 2025 : Clinical Research
Association of Sex with Survival and Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Single-Center Experience in Türkiye
Melike Yüksel YavuzDOI: 10.12659/MSM.947817
Med Sci Monit 2025; 31:e947817
Table 5 Multivariate Cox regression analysis to predict mortality*.
| HR | P | aHR | P | |
|---|---|---|---|---|
| Age | 1.005 (0.957–1.056) | 0.837 | 0.966 (0.945–1.051) | 0.892 |
| Sex (ref. men) | 2.458 (0.979–6.168) | 0.055 | 2.081 (0.734–5.904) | 0.168 |
| Radiotherapy (ref. yes) | 2.657 (1.098–6.428) | 3.311 (1.291–8.492) | ||
| ECOG | 1.871 (1.166–3.002) | 1.744 (3.311–1.291) | ||
| Albumin | 0.901 (0.841–0.966) | 0.907 (0.841–0.977) | ||
| ECOG – Eastern Cooperative Oncology Group. * Adjustments were made for all variables included in the model. | ||||






